Encephalopathy and Nitrogen Metabolism in Liver Failure contains research reports and state-of-the-art reviews that were presented at the 11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism in relation to liver disease, that was held in Amsterdam, The Netherlands from 30 May to 1 June, 2002. Themes covered include the metabolism of ammonia and amino acids in relation to liver disease, the assessment of hepatic encephalopathy (HE), minimal HE, animal models of HE, neuropsychiatric dysfunction in patients with chronic liver disease, the pathogenesis of HE, the…mehr
Encephalopathy and Nitrogen Metabolism in Liver Failure contains research reports and state-of-the-art reviews that were presented at the 11th International Symposium on Hepatic Encephalopathy and Nitrogen Metabolism in relation to liver disease, that was held in Amsterdam, The Netherlands from 30 May to 1 June, 2002. Themes covered include the metabolism of ammonia and amino acids in relation to liver disease, the assessment of hepatic encephalopathy (HE), minimal HE, animal models of HE, neuropsychiatric dysfunction in patients with chronic liver disease, the pathogenesis of HE, the astrocyte in liver disease, acute liver failure and cerebral edema, treatment of HE and artificial liver support systems. This volume provides an indispensable source of important new research findings and ideas for clinicians and biomedical scientists working in the field of HE and nitrogen metabolism in relation to liver disease.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
1. Nitrogen metabolism in relation to liver disease.- 1. Novel aspects of nitrogen metabolism in liver disease.- 2. The interorgan exchange of amino acids and ammonia and the effect of plasmapheresis in acute liver failure.- 3. Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis.- 4. Citrin deficiency.- 2. Assessment of overt and minimal hepatic encephalopathy.- 5. Assessment of hepatic encephalopathy.- 6. Evaluation of mental state in a clinical trial of MARS for patients with acute hepatic encephalopathy: comparison of two scales.- 7. Relationship between minimal hepatic encephalopathy and extrapyramidal signs in cirrhotic patients.- 8. Evaluation of visual focus in cirrhotic patients.- 9. Detection of minimal hepatic encephalopathy: EEG spectral analysis vs. cognitive evoked potentials.- 10. Analysis of critical flicker frequency threshold in hepatic encephalopathy: dynamics and cortical activations.- 11. Cortical origin of mini-asterixis in hepatic encephalopathy.- 12. Imaging studies in hepatic encephalopathy.- 13. Subclinical and overt hepatic encephalopathy - detection and treatment control by proton magnetic resonance spectroscopy (1H-MRS).- 3. Animal models of acute liver failure.- 14. Long-term observations on rats with thioacetamide-induced hepatic failure.- 15. Reversal of Fischer's ratio in an anesthetised porcine model of acute liver failure.- 4. Neuropsychiatric dysfunction in chronic liver disease.- 16. Experience with neuropsychiatrie complications of interferon-based therapy for chronic viral hepatitis.- 17. Cognitive effects of long-term interferon treatment for chronic viral hepatitis.- 18. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?.- 19. Reduced pallidal magnetisationtransfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis.- 5. Pathophysiology of hepatic encephalopathy.- 20. Pathogenesis of hepatic encephalopathy.- 21. Effect of blood plasma components from patients with hepatic encephalopathy on electrophysiological activity of primary frontal cortex networks in vitro.- 22. Hyperammonemia and liver failure alter signal transduction associated with glutamate receptors and modulation of guanylate cyclase by nitric oxide.- 23. Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis.- 24. Concomitant changes in melatonin metabolism and in hypothalamic histamine in rats with a portacaval anastomosis.- 25. Brain energy metabolism in acute liver failure: studies using NMR spectroscopy.- 26. Brain diffusion weighted MRI in cirrhosis.- 27. Role of manganese in hepatic encephalopathy.- 6. Astrocytes and hepatic encephalopathy.- 28. The mitochondrial permeability transition in ammonia neurotoxicity.- 29. Astroglial protein tyrosine nitration by ammonia.- 30. Use of NMR spectroscopy for the study of ammonia metabolism in astrocytes and neurons: role of glutamine synthesis in astrocytes.- 7. Acute liver failure.- 31. Brain uptake of ammonia in fulminant hepatic failure: the role of cerebral blood flow.- 32. Effect of erythropoietin on intracranial pressure and brain water in rats with hyperammonemia.- 33. Prevention of brain edema in acute liver failure by hypothermia: recent advances.- 8. Treatment of hepatic encephalopathy.- 34. Treatment of hepatic encephalopathy.- 35. Rifaximin reduces EEG relative beta power in patients with minimal hepatic encephalopathy: preliminary findings.- 36. Naloxone treatment of human hepatic encephalopathy.- 9. Artificial liver support and hypothermia in liver failure.- 37. Liver support systems: issues and challenges.- 38. Clinical application of bioartificial liver support systems.- 39. Molecular Adsorbents Recirculating System (MARS) for acute decompensation of chronic liver disease: an early clinical experience.- 40. Hypothermia for the management of intracranial hypertension in acute liver failure.- 10. The future.- 41. The potential of molecular biological techniques in research on hepatic encephalopathy.
1. Nitrogen metabolism in relation to liver disease.- 1. Novel aspects of nitrogen metabolism in liver disease.- 2. The interorgan exchange of amino acids and ammonia and the effect of plasmapheresis in acute liver failure.- 3. Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis.- 4. Citrin deficiency.- 2. Assessment of overt and minimal hepatic encephalopathy.- 5. Assessment of hepatic encephalopathy.- 6. Evaluation of mental state in a clinical trial of MARS for patients with acute hepatic encephalopathy: comparison of two scales.- 7. Relationship between minimal hepatic encephalopathy and extrapyramidal signs in cirrhotic patients.- 8. Evaluation of visual focus in cirrhotic patients.- 9. Detection of minimal hepatic encephalopathy: EEG spectral analysis vs. cognitive evoked potentials.- 10. Analysis of critical flicker frequency threshold in hepatic encephalopathy: dynamics and cortical activations.- 11. Cortical origin of mini-asterixis in hepatic encephalopathy.- 12. Imaging studies in hepatic encephalopathy.- 13. Subclinical and overt hepatic encephalopathy - detection and treatment control by proton magnetic resonance spectroscopy (1H-MRS).- 3. Animal models of acute liver failure.- 14. Long-term observations on rats with thioacetamide-induced hepatic failure.- 15. Reversal of Fischer's ratio in an anesthetised porcine model of acute liver failure.- 4. Neuropsychiatric dysfunction in chronic liver disease.- 16. Experience with neuropsychiatrie complications of interferon-based therapy for chronic viral hepatitis.- 17. Cognitive effects of long-term interferon treatment for chronic viral hepatitis.- 18. Is fatigue of cholestasis mediated by altered central serotoninergic neurotransmission?.- 19. Reduced pallidal magnetisationtransfer ratios are associated with fatigue in pre-cirrhotic patients with primary biliary cirrhosis.- 5. Pathophysiology of hepatic encephalopathy.- 20. Pathogenesis of hepatic encephalopathy.- 21. Effect of blood plasma components from patients with hepatic encephalopathy on electrophysiological activity of primary frontal cortex networks in vitro.- 22. Hyperammonemia and liver failure alter signal transduction associated with glutamate receptors and modulation of guanylate cyclase by nitric oxide.- 23. Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis.- 24. Concomitant changes in melatonin metabolism and in hypothalamic histamine in rats with a portacaval anastomosis.- 25. Brain energy metabolism in acute liver failure: studies using NMR spectroscopy.- 26. Brain diffusion weighted MRI in cirrhosis.- 27. Role of manganese in hepatic encephalopathy.- 6. Astrocytes and hepatic encephalopathy.- 28. The mitochondrial permeability transition in ammonia neurotoxicity.- 29. Astroglial protein tyrosine nitration by ammonia.- 30. Use of NMR spectroscopy for the study of ammonia metabolism in astrocytes and neurons: role of glutamine synthesis in astrocytes.- 7. Acute liver failure.- 31. Brain uptake of ammonia in fulminant hepatic failure: the role of cerebral blood flow.- 32. Effect of erythropoietin on intracranial pressure and brain water in rats with hyperammonemia.- 33. Prevention of brain edema in acute liver failure by hypothermia: recent advances.- 8. Treatment of hepatic encephalopathy.- 34. Treatment of hepatic encephalopathy.- 35. Rifaximin reduces EEG relative beta power in patients with minimal hepatic encephalopathy: preliminary findings.- 36. Naloxone treatment of human hepatic encephalopathy.- 9. Artificial liver support and hypothermia in liver failure.- 37. Liver support systems: issues and challenges.- 38. Clinical application of bioartificial liver support systems.- 39. Molecular Adsorbents Recirculating System (MARS) for acute decompensation of chronic liver disease: an early clinical experience.- 40. Hypothermia for the management of intracranial hypertension in acute liver failure.- 10. The future.- 41. The potential of molecular biological techniques in research on hepatic encephalopathy.
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
